Keybank National Association Reata Pharmaceuticals Inc Transaction History

Keybank National Association

  • $25.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 28, 2022
BUY
$24.12 - $39.6 $367,830 - $603,900
15,250 New
15,250 $500,000
Q4 2021

Feb 07, 2022
SELL
$25.61 - $110.96 $256,100 - $1.11 Million
-10,000 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$78.27 - $151.29 $156,540 - $302,580
2,000 Added 25.0%
10,000 $1.42 Million
Q1 2021

May 07, 2021
BUY
$94.25 - $132.81 $188,500 - $265,620
2,000 Added 33.33%
8,000 $798,000
Q4 2020

Feb 09, 2021
BUY
$102.03 - $184.62 $612,180 - $1.11 Million
6,000 New
6,000 $742,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email